Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Jefferies Raises Antofagasta To Buy From Hold

Thu, 24th Jul 2014 09:13

LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning:
----------
FTSE 100
----------
JEFFERIES RAISES ASSOCIATED BRITISH FOODS TARGET TO 2,950 (2,600) PENCE. -'HOLD'
----------
BERENBERG CUTS BABCOCK INTERNATIONAL PRICE TARGET TO 1,480 (1,510) PENCE. - 'BUY'
----------
NUMIS RAISES ARM TO 'BUY' ('HOLD') - TARGET 1,150 (920) PENCE
----------
UBS CUTS ARM PRICE TARGET TO 970 (1050) PENCE - 'NEUTRAL'
----------
SOCGEN CUTS GLAXOSMITHKLINE PRICE TARGET TO 1900 (2100) PENCE - 'BUY'
----------
EXANE BNP CUTS GLAXOSMITHKLINE PRICE TARGET TO 1550 (1600) PENCE - 'UNDERPERFORM'
----------
LBBW CUTS GLAXOSMITHKLINE PRICE TARGET TO 1600 (1650) PENCE - 'HOLD'
----------
DEUTSCHE BANK CUTS GLAXOSMITHKLINE PRICE TARGET TO 1500 (1630) PENCE - 'HOLD'
----------
LIBERUM RAISES CAPITA GROUP PRICE TARGET TO 1,175 (1,100) PENCE - 'HOLD'
----------
MORGAN STANLEY RAISES CAPITA GROUP TARGET TO 1,150 (1,100) PENCE - 'EQUAL-WEIGHT'
----------
BARCLAYS RAISES CAPITA GROUP PRICE TARGET TO 1,280 (1,050) PENCE. - 'EQUAL WEIGHT'
----------
DEUTSCHE BANK RAISES BHP BILLITON PRICE TARGET TO 2450 (2400) PENCE - 'BUY'
----------
JEFFERIES RAISES BHP BILLITON PRICE TARGET TO 2450 (2200) PENCE - 'BUY'
----------
JEFFERIES RAISES RIO TINTO PRICE TARGET TO 4100 (3900) PENCE - 'BUY'
----------
JEFFERIES RAISES ANTOFAGASTA TO 'BUY' ('HOLD') - TARGET 1,000 (825) PENCE
----------
JEFFERIES RAISES ANGLO AMERICAN PRICE TARGET TO 1,700 (1,550) PENCE - 'HOLD'
----------
JPMORGAN CUTS TULLOW OIL PRICE TARGET TO 1,000 (1,050) PENCE - 'OVERWEIGHT'
----------
HSBC CUTS ADMIRAL GROUP TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 1,700 (1,800) PENCE
----------
EXANE BNP CUTS MORRISON PRICE TARGET TO 155 (175) PENCE - 'UNDERPERFORM'
----------
PANMURE RAISES EASYJET TO 'BUY' ('HOLD') - TARGET 1,800 PENCE
----------
NUMIS RAISES JOHNSON MATTHEY TO 'BUY' ('ADD') - TARGET 3,642 PENCE
----------
NUMIS CUTS SAGE GROUP PRICE TARGET TO 396 (411) PENCE - 'HOLD'
----------
FTSE 250
----------
JPMORGAN CUTS JLT GROUP PRICE TARGET TO 1,208 (1,216) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS SOCO INTERNATIONAL PRICE TARGET TO 395 (407) PENCE - 'NEUTRAL'
----------
UBS RAISES RENISHAW PRICE TARGET TO 1850 (1700) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES PROVIDENT FINANCIAL PRICE TARGET TO 2,200 (2,050) P. - 'HOLD'
----------
BARCLAYS CUTS KAZAKHMYS PRICE TARGET TO 220 (235) PENCE - 'EQUAL WEIGHT'
----------
DEUTSCHE BANK RAISES KAZAKHMYS TO 'HOLD' ('SELL') - TARGET 310 (201) PENCE
----------
UBS REMOVES KAZAKHMYS FROM 'EURO METALS LEAST PREFERRED LIST'
----------
HSBC INITIATES KAZAKHMYS WITH 'NEUTRAL' - TARGET 360 PENCE
----------
JEFFERIES RAISES KAZAKHMYS PRICE TARGET TO 350 (300) PENCE - 'HOLD'
----------
BARCLAYS CUTS LADBROKES PRICE TARGET TO 137 (142) PENCE - 'UNDERWEIGHT'
----------
DEUTSCHE BANK CUTS ULTRA ELECTRONICS PRICE TARGET TO 1,750 (1,765) P. - 'HOLD'
----------
JEFFERIES RAISES VEDANTA PRICE TARGET TO 1,200 (900) PENCE - 'HOLD'
----------
CITIGROUP CUTS MORGAN ADVANCED MATERIALS TARGET TO 340 (345) PENCE - 'BUY'
----------
JPMORGAN RAISES AFREN TO 'OVERWEIGHT' ('UNDERWEIGHT') - TARGET 188 (180) PENCE
----------
JPMORGAN CUTS OPHIR ENERGY TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 270 (330) PENCE
----------
JPMORGAN RAISES ENTERTAINMENT ONE TARGET TO 365 (323) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS CAIRN ENERGY PRICE TARGET TO 271 (279) PENCE - 'OVERWEIGHT'
----------
NUMIS RAISES LANCASHIRE HLDGS TO 'BUY' ('ADD') - TARGET 840 (875) PENCE
----------
NUMIS CUTS CRODA PRICE TARGET TO 2,178 (2,248) PENCE - 'HOLD'
----------
CANACCORD RAISES RATHBONE BROS TO 'BUY' ('HOLD') - TARGET 2,160 PENCE
----------
NUMIS CUTS MITCHELLS & BUTLERS TO 'HOLD' ('BUY') - TARGET 420 (525) PENCE
----------
SOCGEN CUTS DRAX GROUP TO 'SELL' ('HOLD') - TARGET 630 (680) PENCE
----------
MAIN MARKET AND AIM
----------
JEFFERIES RAISES FIRST QUANTUM TARGET TO 1,700 (1,350) PENCE - 'BUY'
----------
CITIGROUP RAISES PETROPAVLOVSK TO 'NEUTRAL' ('SELL') - TARGET 42 (67) PENCE
----------
JPMORGAN RAISES GENEL ENERGY PRICE TARGET TO 1,170 (1,160) PENCE - 'NEUTRAL'
----------
LIBERUM RAISES VERTU MOTORS PRICE TARGET TO 100 (85) PENCE - 'BUY'
----------
NUMIS CUTS SAGENTIA GROUP PRICE TARGET TO 150 (180) PENCE - 'ADD'
----------
UBS CUTS PREMIER FOODS PRICE TARGET TO 50 (55) PENCE - 'NEUTRAL'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.


More News
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.